Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion type Assertion NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_head.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion description "[The activity of LMP1 promoter ED-L1 in type III latent infection was strongly suppressed by triptolide treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_provenance.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion evidence source_evidence_literature NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_provenance.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion SIO_000772 25511707 NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_provenance.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion wasDerivedFrom befree-2016 NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_provenance.
- NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_assertion wasGeneratedBy ECO_0000203 NP1248351.RAxuAvacKO5xS8OtlehjSf-PL3P8W6O24TQW33dUe8HHA130_provenance.